[
  { "id":"METFORMIN", "label":"Metformin",
    "tags":["First-line","Weight neutral/slight loss"],
    "gates":["EGFR>=30"],
    "hints":["Titrate slow; B12 monitoring"],
    "sourceKeys":["ADA-S009-metformin"] },

  { "id":"SGLT2I", "label":"SGLT2 inhibitor (class)",
    "tags":["Cardiorenal benefit","Weight loss (modest)","Low hypo risk"],
    "gates":["EGFR>=20","PeriOpHold"],
    "hints":["CV/Kidney risk reduction; glycemic effect ↓ if eGFR<45"],
    "sourceKeys":["ADA-S009-SGLT2","ADA-S016-Periop"] },

  { "id":"GLP1RA", "label":"GLP-1 receptor agonist (class)",
    "tags":["ASCVD/MACE benefit","Weight loss (high)","Low hypo risk"],
    "gates":["PeriOpCaution"],
    "hints":["Individualize around anesthesia; GI titration"],
    "sourceKeys":["ADA-S009-GLP1","ADA-S016-GLP1-periop"] },

  { "id":"DUAL_GIP_GLP1", "label":"Dual GIP/GLP-1 RA (e.g., tirzepatide)",
    "tags":["Very high glycemic efficacy","Very high weight loss"],
    "gates":[],
    "hints":["Consider in obesity + T2D"],
    "sourceKeys":["ADA-S009-dual"] },

  { "id":"DPP4I", "label":"DPP-4 inhibitor (class)",
    "tags":["Weight neutral","Low hypo risk"],
    "gates":["Caution_HF_SAXA"],
    "hints":["Linagliptin no renal dose change"],
    "sourceKeys":["ADA-S009-DPP4"] },

  { "id":"TZD", "label":"Thiazolidinedione (pioglitazone)",
    "tags":["High glycemic efficacy","Weight gain"],
    "gates":["Avoid_HF"],
    "hints":["Edema; fracture; bladder cancer caution"],
    "sourceKeys":["ADA-S009-TZD"] },

  { "id":"SULFONYLUREA", "label":"Sulfonylurea (class)",
    "tags":["High glycemic efficacy","Hypoglycemia risk","Weight gain"],
    "gates":[],
    "hints":["Prefer newer agents; caution in CKD/older"],
    "sourceKeys":["ADA-S009-SU"] },

  { "id":"MEGLITINIDE", "label":"Meglitinide",
    "tags":["Meals-based dosing","Hypoglycemia risk (less than SU)"],
    "gates":[],
    "hints":["Short acting; consider meal patterns"],
    "sourceKeys":["ADA-S009-meglitinide"] },

  { "id":"ALPHA_GLUCO_INHIB", "label":"α-Glucosidase inhibitor",
    "tags":["Postprandial focus","GI effects"],
    "gates":[],
    "hints":["Flatulence/diarrhea common"],
    "sourceKeys":["ADA-S009-AGI"] },

  { "id":"COLESEVELAM", "label":"Bile acid sequestrant (colesevelam)",
    "tags":["Modest A1c effect","Lipid benefit"],
    "gates":[],
    "hints":["Constipation; TG caution"],
    "sourceKeys":["ADA-S009-colesevelam"] },

  { "id":"BROMOQR", "label":"Bromocriptine-QR",
    "tags":["Modest A1c effect"],
    "gates":[],
    "hints":["Orthostasis, nausea"],
    "sourceKeys":["ADA-S009-bromocriptine"] },

  { "id":"PRAMLINTIDE", "label":"Pramlintide (amylin analog)",
    "tags":["Adjunct to insulin","Postprandial flattening"],
    "gates":[],
    "hints":["Mostly T1D; nausea; hypo w/ insulin if not reduced"],
    "sourceKeys":["ADA-S009-pramlintide"] },

  { "id":"BASAL_ANALOG", "label":"Basal insulin analog (glargine U100/U300, degludec, detemir)",
    "tags":["High efficacy","Hypoglycemia risk","Weight gain"],
    "gates":[],
    "hints":["Lower nocturnal hypo vs NPH (class-dependent)"],
    "sourceKeys":["ADA-S009-insulin"] },

  { "id":"BASAL_NPH", "label":"Basal insulin NPH",
    "tags":["High efficacy","Hypoglycemia risk","Weight gain"],
    "gates":[],
    "hints":["More nocturnal hypo vs analogs"],
    "sourceKeys":["ADA-S009-insulin"] },

  { "id":"BOLUS_ANALOG", "label":"Prandial insulin analog (lispro/aspart/glulisine)",
    "tags":["High efficacy","Hypoglycemia risk","Weight gain"],
    "gates":[],
    "hints":["Lower hypo vs human regular in some studies"],
    "sourceKeys":["ADA-S009-insulin"] },

  { "id":"REGULAR_INSULIN", "label":"Human regular insulin",
    "tags":["High efficacy","Hypoglycemia risk","Weight gain"],
    "gates":[],
    "hints":["Inject 30 min pre-meal"],
    "sourceKeys":["ADA-S009-insulin"] },

  { "id":"PREMIXED_INSULIN", "label":"Premixed insulin (70/30, 75/25, 50/50)",
    "tags":["High efficacy","Hypoglycemia risk","Less flexible"],
    "gates":[],
    "hints":["More hypo vs basal-bolus inpatient; not routine in hospital"],
    "sourceKeys":["ADA-S016-insulin"] },

  { "id":"BASAL_INSULIN", "label":"Basal insulin (inpatient, class)",
    "tags":["Inpatient standard","High efficacy","Hypoglycemia risk"],
    "gates":[],
    "hints":["Prefer basal ± prandial correction inpatient; analogs reduce nocturnal hypo vs NPH"],
    "sourceKeys":["ADA-S016-BasalBolus"] },

  { "id":"IV_INSULIN", "label":"IV insulin infusion (hospital/ICU)",
    "tags":["Critical care","Tight titration"],
    "gates":[],
    "hints":["Validated protocols; targets per setting"],
    "sourceKeys":["ADA-S016-IV"] }
]